Physician profile
Jason Arora
NPI 1144582206
$1,292.59
in general payments reported to CMS, 2019-2025
9 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.95 · 2020: $37.59 · 2021: $64.43 · 2022: $88.70 · 2023: $777 · 2024: $202 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.11 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $327.02 | 2020-2023 | Vapr, Fms, Milagro |
| Boston Scientific Corporation | $222.90 | 2021-2023 | |
| Djo, LLC | $195.72 | 2023-2025 | Cmf |
| Nevro Corp. | $195.10 | 2023 | Senza |
| Saluda Medical Americas, INC. | $182.47 | 2023-2024 | Evoke, Evoke Scs |
| Abbott Laboratories | $72.52 | 2021-2022 | |
| Medtronic, INC. | $60.32 | 2023 | Intellis Adaptivestim |
| Surgalign Spine Technologies, INC. | $22.59 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.